Step 1 topics → Microbiology → Pseudomonas aeruginosa

Pseudomonas aeruginosa

USMLE Step 1 trap: Overlooks that Pseudomonas Exotoxin A and diphtheria toxin share the EF-2 ADP-ribosylation mechanism. Pseudomonas Exotoxin A and diphtheria toxin share the same mechanism—ADP-ribosylation of EF-2—but differ in receptor and structure.

Pseudomonas aeruginosa is a gram-negative, aerobic rod that thrives in wet environments and is nearly impossible to eradicate once established in a host with compromised defenses, making it a high-yield pathogen for USMLE Step 1. A classic exam trap here is Exotoxin A: students assume it works differently from diphtheria toxin since they're from completely different organisms — but both ADP-ribosylate EF-2 and halt protein synthesis at the same step. It produces blue-green pigment (pyocyanin), has a characteristic grape-like odor, and is intrinsically resistant to many antibiotics. The exam tests this organism from multiple angles: pure recall of lab features, clinical pattern recognition across different host types, mechanism of Exotoxin A, and treatment strategy. You need to know all of them.

The trickiest part of this topic is that students compartmentalize Pseudomonas as 'the burn patient bug' and miss the full clinical picture. USMLE Step 1 loves to present a diabetic with ear pain, a CF patient with recurrent pneumonia, or a healthy person with folliculitis after a hot tub — and you need to recognize Pseudomonas in all of these contexts, not just burns. The organism follows the pattern of opportunist: it hits hosts where normal defenses are broken (skin barrier in burns, airway clearance in CF, skin in water exposure, immune function in neutropenia).

The other classic trap is Exotoxin A mechanism. Students remember that diphtheria toxin ADP-ribosylates EF-2 and then assume Pseudomonas must work differently since it's a completely different organism. It doesn't — Exotoxin A uses the exact same biochemical mechanism. The difference is receptor and structure, not the intracellular target. If you blur this, you'll miss questions that test comparative toxin mechanisms, which appear on USMLE Step 1 more often than students expect.

From real student decks
92%have cards covering this topic
81%have mature cards

Well-covered in most decks — the challenge is retention, not exposure.

Common misconceptions

Common mistake
Wrong: Pseudomonas Exotoxin A has a different mechanism than diphtheria toxin.
Right: Pseudomonas Exotoxin A and diphtheria toxin share the same mechanism—ADP-ribosylation of EF-2—but differ in receptor and structure.
Pseudomonas Exotoxin A and diphtheria toxin both inhibit protein synthesis by ADP-ribosylating EF-2 (elongation factor 2), which halts translation — so the intracellular mechanism is identical. What differs is how they get into cells: diphtheria toxin binds the EGF-like receptor while Exotoxin A uses a different host receptor (LRP1/alpha-2-macroglobulin receptor). Don't let the different organism names fool you into thinking the downstream biochemistry is different — the exam specifically exploits this assumption.
Common mistake
Wrong: Pseudomonas infections occur only in burn patients.
Right: Pseudomonas causes infections across multiple settings: burn wounds, CF lung infections, hot tub folliculitis, malignant otitis externa in diabetics, and ventilator-associated pneumonia.
Pseudomonas isn't just a burn pathogen — it's an opportunist that attacks wherever normal host defenses are disrupted. Burns break the skin barrier; CF disrupts mucociliary clearance and creates a thick mucus environment Pseudomonas loves; diabetes impairs neutrophil function and vascular supply (especially in the ear canal); prolonged ICU stays with ventilators bypass upper airway defenses. Hot tub folliculitis is the one setting involving otherwise healthy hosts — the organism just exploits high-moisture, high-pH water. Learn the host-setting pairs, not just a single association.
Common mistake
Wrong: Monotherapy with a single antipseudomonal agent is adequate for serious Pseudomonas infections.
Right: Serious Pseudomonas infections typically require combination therapy (e.g., antipseudomonal beta-lactam plus an aminoglycoside or fluoroquinolone) to prevent resistance emergence.
Pseudomonas has multiple intrinsic and acquired resistance mechanisms — efflux pumps, beta-lactamases, porin mutations — and it acquires new resistance rapidly under antibiotic pressure. Using a single agent for serious infections selects for resistant mutants fast enough to cause clinical failure mid-treatment. Combination therapy (antipseudomonal beta-lactam + aminoglycoside or fluoroquinolone) targets different bacterial processes simultaneously, reducing the probability that a single mutation confers full resistance. This is one of the few situations in infectious disease where combination therapy has a clear pharmacodynamic rationale beyond just spectrum coverage.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know the key lab features that identify Pseudomonas aeruginosa: gram-negative rod, oxidase-positive, non-lactose fermenter, blue-green pyocyanin pigment, and fruity/grape-like odor on culture.
  2. Recognize Pseudomonas as the causative pathogen across specific clinical settings — burn wound infections, CF chronic lung colonization, hot tub folliculitis, malignant otitis externa in diabetics, and ventilator-associated pneumonia in ICU patients.
  3. Understand that serious Pseudomonas infections require combination therapy using an antipseudomonal beta-lactam (piperacillin-tazobactam, cefepime, meropenem) paired with an aminoglycoside or fluoroquinolone, and know why monotherapy risks rapid resistance.

Can you avoid these mistakes?

A sputum culture from a 19-year-old with cystic fibrosis grows a gram-negative rod that is oxidase-positive, produces blue-green colonies, and has a fruity odor. What organism is this, and what pigment is responsible for the color?
A 67-year-old diabetic man presents with severe left ear pain, purulent drainage, and granulation tissue at the external auditory canal. Which organism is most likely, and what makes this patient specifically vulnerable to this infection?
A vignette describes Pseudomonas Exotoxin A causing cell death. A student says this toxin works differently than diphtheria toxin. Is the student correct? What is the shared mechanism, and what actually differs between the two toxins?
A patient with Pseudomonas bacteremia is being treated with piperacillin-tazobactam alone. The attending wants to add an aminoglycoside. What is the rationale for combination therapy here, and what risk does monotherapy specifically carry with this organism?

Related topics

Bacterial Exotoxins Bacterial Staining and Structure Bacterial Culture Requirements Encapsulated Organisms

See how your Anki deck covers this topic.

Upload your deck for a free audit →